Panion & Bf Biotech Inc

TPE:1760 (Taiwan)  
NT$ 97.50 (-1.71%) Jun 24
85.53
P/B:
4.56
Market Cap:
NT$ 8.36B ($ 258.23M)
Enterprise V:
NT$ 8.57B ($ 264.72M)
Volume:
347.01K
Avg Vol (2M):
351.03K
Trade In:
Volume:
347.01K
Avg Vol (2M):
351.03K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Panion & Bf Biotech Inc ( TPE:1760 ) from 2004 to Jun 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Panion & Bf Biotech stock (TPE:1760) PE ratio as of Jun 24 2024 is 85.53. More Details

Panion & Bf Biotech Inc (TPE:1760) PE Ratio (TTM) Chart

To

Panion & Bf Biotech Inc (TPE:1760) PE Ratio (TTM) Historical Data

Total 1221
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Panion & Bf Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-25 85.5 2024-04-18 88.6
2024-06-21 87.0 2024-04-17 89.9
2024-06-20 86.2 2024-04-16 89.5
2024-06-19 85.5 2024-04-15 90.3
2024-06-18 86.2 2024-04-12 91.2
2024-06-17 86.0 2024-04-11 96.0
2024-06-14 84.4 2024-04-10 94.7
2024-06-13 85.3 2024-04-09 96.5
2024-06-12 86.4 2024-04-08 97.4
2024-06-11 87.5 2024-04-03 100.0
2024-06-07 85.7 2024-04-02 98.7
2024-06-06 84.9 2024-04-01 97.4
2024-06-05 85.8 2024-03-29 96.5
2024-06-04 84.3 2024-03-28 98.3
2024-06-03 84.5 2024-03-27 125.3
2024-05-31 84.2 2024-03-26 119.1
2024-05-30 83.5 2024-03-25 119.7
2024-05-29 84.8 2024-03-22 118.0
2024-05-28 85.5 2024-03-21 117.4
2024-05-27 83.8 2024-03-20 116.3
2024-05-24 83.7 2024-03-19 115.2
2024-05-23 83.4 2024-03-18 115.7
2024-05-22 85.0 2024-03-15 114.0
2024-05-21 85.3 2024-03-14 114.6
2024-05-20 85.7 2024-03-13 114.0
2024-05-17 86.1 2024-03-12 114.6
2024-05-16 84.6 2024-03-11 113.5
2024-05-15 84.0 2024-03-08 112.9
2024-05-14 83.7 2024-03-07 116.3
2024-05-13 83.1 2024-03-06 114.6
2024-05-10 82.5 2024-03-05 114.6
2024-05-09 82.9 2024-03-04 114.0
2024-05-08 84.6 2024-03-01 114.6
2024-05-07 84.8 2024-02-29 116.8
2024-05-06 84.7 2024-02-27 116.3
2024-05-03 84.9 2024-02-26 119.1
2024-05-02 85.4 2024-02-23 116.3
2024-04-30 84.3 2024-02-22 118.5
2024-04-29 85.4 2024-02-21 119.1
2024-04-26 84.7 2024-02-20 119.1
2024-04-25 85.2 2024-02-19 119.1
2024-04-24 86.4 2024-02-16 119.7
2024-04-23 86.4 2024-02-15 116.8
2024-04-22 85.2 2024-02-09 115.2
2024-04-19 84.5 2024-02-08 115.2

Panion & Bf Biotech Inc (TPE:1760) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company along with its subsidiaries is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generates a majority of its revenue from the Taiwan segment.